📊 Get daily AI-graded market briefings
Morning + evening · AI impact + sector exposure · Free
LAST 30 DAYS
4 articles
AVG GRADE
NEUTRAL
score: 0.38
SENTIMENT
NEUTRAL
TOTAL VIEWS
6
RECENT COVERAGE · 5 ARTICLES
Is Bristol-Myers Squibb Company (BMY) Stock at Risk From Proposed Medicare Drug Price Negotiation Updates?
Bristol-Myers Squibb (BMY) faces potential headwinds from proposed updates to the Medicare Drug Price Negotiation Program, a regulatory...
Bristol Myers Squibb vs. Johnson & Johnson: Which Healthcare Stock Is a Better Buy in 2026?
Bristol Myers Squibb (BMY) and Johnson & Johnson (JNJ) represent divergent strategies within large-cap healthcare. BMY's positioning in...
Bristol-Myers Squibb Company declares $0.63 dividend (NYSE:BMY)
Bristol-Myers Squibb (BMY) has declared a quarterly dividend of $0.63 per share, maintaining consistency with its previous distribution...
How Safe is Bristol Myers Squibb's Dividend? Here's My Honest Take.
Bristol Myers Squibb (BMY) is the focal point of this dividend safety assessment, with the company offering a 4.5% yield that...
Bristol Myers Squibb Dividend Raise Streak is 18 Years. Here's 1 Number That Says the Streak Will Continue.
Bristol Myers Squibb (BMY) continues to demonstrate capital allocation discipline through an 18-year consecutive dividend increase...
RELATED TICKERS
E
ESEN Analytics
AI-powered equity research platform covering 5,000+ US equities. Our proprietary AI grading system (A+ to D scale) analyzes fundamentals, technicals, and news sentiment daily. Coverage data updated every 24 hours.
Learn about our methodology →
ⓘ AI-graded news coverage · Not investment advice